Cynvenio Biosystems Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cynvenio Biosystems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10874
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that focuses on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood. The company offers products such as lab automation systems, isolation products and proprietary informatics software solutions for sequence analysis. It offers CLIA and CAP Lab Services such as liquid biopsy test and monitoring immune system health, and testing for CRO and pharma industries. The company also provides NK Vue, a vitro test that measures the activity of NK cells and monitor immune system health. It works in partnership with clinicians, and oncologists. Cynvenio is headquartered in Westlake Village, California, the US.

Cynvenio Biosystems Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cynvenio Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cynvenio Biosystems Raises USD1.75 Million in Venture Financing 11
Cynvenio Biosystems Raises USD25.5 Million in Series B Equity Financing 12
Cynvenio Biosystems Raises USD25.4 Million in Venture Financing 13
Cynvenio Biosystems Raises Additional USD1 Million in Venture Financing 14
Cynvenio Biosystems Raises USD1.8 Million in Venture Financing 15
Cynvenio Biosystems Raises US$1.4 Million In Series B-4 Financing 16
Cynvenio Biosystems Raises US$2 Million In Venture Financing 17
Cynvenio Biosystems Raises USD1.8 Million in Venture Financing 18
Cynvenio Biosystems Raises Additional US$0.8 Million In Series B Financing 19
Partnerships 20
Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 20
Equity Offering 21
Cynvenio Biosystems Raises USD10 Million in Private Placement of Series B Preferred Shares 21
Cynvenio Biosystems Inc – Key Competitors 22
Cynvenio Biosystems Inc – Key Employees 23
Cynvenio Biosystems Inc – Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Key Facts 2
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cynvenio Biosystems Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Cynvenio Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cynvenio Biosystems Raises USD1.75 Million in Venture Financing 11
Cynvenio Biosystems Raises USD25.5 Million in Series B Equity Financing 12
Cynvenio Biosystems Raises USD25.4 Million in Venture Financing 13
Cynvenio Biosystems Raises Additional USD1 Million in Venture Financing 14
Cynvenio Biosystems Raises USD1.8 Million in Venture Financing 15
Cynvenio Biosystems Raises US$1.4 Million In Series B-4 Financing 16
Cynvenio Biosystems Raises US$2 Million In Venture Financing 17
Cynvenio Biosystems Raises USD1.8 Million in Venture Financing 18
Cynvenio Biosystems Raises Additional US$0.8 Million In Series B Financing 19
Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 20
Cynvenio Biosystems Raises USD10 Million in Private Placement of Series B Preferred Shares 21
Cynvenio Biosystems Inc, Key Competitors 22
Cynvenio Biosystems Inc, Key Employees 23

List of Figures
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cynvenio Biosystems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cynvenio Biosystems Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Cynvenio Biosystems Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Coca-Cola FEMSA SAB de CV:企業の戦略・SWOT・財務情報
    Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola FEMSA SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Stanbic Ibtc Holdings Plc:企業の戦略・SWOT・財務分析
    Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Stanbic Ibtc Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cable & Wireless Communications Ltd:企業の戦略的SWOT分析
    Cable & Wireless Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SOHO Global Health:企業の戦略的SWOT分析
    SOHO Global Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Kylemore Services Group:企業の戦略・SWOT・財務分析
    Kylemore Services Group - Strategy, SWOT and Corporate Finance Report Summary Kylemore Services Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • bet-at-home.com AG (ACX):企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Maruha Nichiro Corporation:戦略・SWOT・企業財務分析
    Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report Summary Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Aushon BioSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aushon BioSystems Inc (Aushon) is a medical device provider that provides biomarker measurement and analysis products. The company offers biomarker therapeutic areas in microarray printing technology. It provides products such as ciraplex assay, cirascan imaging and cirasoft analysis and cir …
  • Edinburgh Molecular Imaging Ltd:企業の製品パイプライン分析2018
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM I …
  • Morrison & Foerster LLP:企業の戦略的SWOT分析
    Morrison & Foerster LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Cheung Kong Infrastructure Holdings Ltd:戦略・SWOT・企業財務分析
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • PetVivo Holdings Inc (PETV):企業の製品パイプライン分析2018
    Summary PetVivo Holdings Inc (PetVivo Holdings), formerly Technologies Scan Corp, is a biomedical device company. The company offers licensing and commercialization of medical devices and therapeutics to treat pets and animals suffering from arthritis and other afflictions. Its products include Kush …
  • Tecan Group Ltd (TECN):製薬・医療:M&Aディール及び事業提携情報
    Summary Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation sup …
  • Finder Exploration Pty Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Finder Exploration Pty Ltd (Finder) is an oil and gas company that acquires and explores prospective acreage. The company offers acquisition of prospective acreage through drilling and detailed assessment and risk mitigation of exploration acreage. It holds exploration operations in Bedout S …
  • Global Franchise Architects Co.,Ltd.:企業の戦略・SWOT・財務分析
    Global Franchise Architects Co.,Ltd. - Strategy, SWOT and Corporate Finance Report Summary Global Franchise Architects Co.,Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • EaglePicher Technologies LLC:企業の戦略的SWOT分析
    EaglePicher Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • ViraTherapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ViraTherapeutics GmbH (ViraTherapeutics) is a biotechnology company that develops high potential anti-cancer therapeutics based on cancer-destroying oncolytic viruses. The company provides VSV-GP which is a proprietary oncolytic virus platform, which helps in destroying cancer cells and is u …
  • Belize Electricity Ltd:企業の戦略的SWOT分析
    Belize Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Bristow Group Inc:企業の戦略・SWOT・財務情報
    Bristow Group Inc - Strategy, SWOT and Corporate Finance Report Summary Bristow Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Equinor ASA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Equinor ASA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆